Since the discovery of L-DOPA as potential ligand for GPR143, many studies have been conducted based on this finding, for example clinical studies to evaluate L-DOPA as a therapy for ocular albinism, which were not conclusive (Summers et al., 2014). This evidence concerns the gene GPR143 and ocular albinism.